Sai Life Sciences faces GST demand of around 33 crore over input tax credit claim

Regulatory & Legal View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹908.00

prior close

₹907.85

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%-1.7% vs market

Pharmaceuticals peers, median of 155sector+0.2%-1.1% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Smallcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.3

15m

-0.2

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+0.8-1.7+0.2-1.1

Next day

-0.1+1.2-1.3-0.1-0.0

-0.9+0.4-1.3-0.5-0.4

-3.1-0.3-2.8-1.2-1.9

-4.0-0.4-3.5-1.4-2.6

+1.1+0.9+0.2-0.6+1.7

-0.8+2.3-3.1+0.5-1.3

15d

+5.3+3.6+1.7+0.5+4.8

-1.7-1.0-0.7-2.7+1.1

+2.1-0.1+2.2-3.3+5.4

+11.0-6.1+17.1-8.6+19.6

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences received a GST order from the Bidar tax authority demanding about 16.28 crore IGST, plus 13.31 crore interest and 3.26 crore penalty, totaling about 32.85 crore. The demand relates to alleged excess input tax credit claimed in GSTR-3B versus GSTR-2A for FY2021-22. The company plans to file an appeal and expects a favourable outcome.

Likely market impact

Company will appeal and sees no material financial impact, but outcome remains uncertain for shareholders.